June 30, 2020 Price forecast | 2 weeks: 1.07% | 1 month: -0.97% | 3 months: -3.30%

RMTI stock forecast

Our latest prediction for Rockwell Medical, Inc.'s stock price was made on the June 30, 2020 when the stock price was at 1.95$.

In the short term (2weeks), RMTI's stock price should outperform the market by 1.07%. During that period the price should oscillate between -9.89% and +13.05%.

In the medium term (3months), RMTI's stock price should underperform the market by -3.30%. During that period the price should oscillate between -37.23% and +33.22%.

Create a solid portfolio with RMTI

Add RMTI to your portfolio and optimize it!

About Rockwell Medical, Inc.

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

At the moment the company generates 62M USD in revenues.

On its last earning announcement, the company reported a loss of -0.53$ per share.

The book value per share is 0.33$

Rockwell Medical, Inc. website

Three months stock forecastJune 30, 2020


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
62M 4.80% -33M -54.10% -33M -0.53 - - 64M 0.33 -28M -1M -30M